ID
28574
Description
Study part: Intraocular Pressure Month 6. A Phase III, Multicenter, Randomized, Double-Masked, Active Treatment-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne®) Photodynamic Therapy In Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration.
Keywords
Versions (1)
- 1/22/18 1/22/18 -
Copyright Holder
Roche
Uploaded on
January 22, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Intraocular Pressure Month 6 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2587g
Intraocular Pressure Month 6
- StudyEvent: ODM
Description
INTRAOCULAR PRESSURE (MONTH 6) 60 MIN POST- DOSE
Alias
- UMLS CUI-1
- C0578862
- UMLS CUI-2
- C0439568
Description
Study eye
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0008972
- UMLS CUI [1,2]
- C0015392
Description
Intraocular Pressure
Data type
integer
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0578862
Description
Date
Data type
date
Alias
- UMLS CUI [1]
- C0011008
Description
time
Data type
time
Alias
- UMLS CUI [1]
- C0040223
Description
Method must be consistent for a subject throughout the study.
Data type
text
Alias
- UMLS CUI [1,1]
- C0430888
- UMLS CUI [1,2]
- C0871511
Similar models
Intraocular Pressure Month 6
- StudyEvent: ODM
C0439565 (UMLS CUI-2)
C2986440 (UMLS CUI [1,2])
C0229089 (UMLS CUI [1,2])
C0229089 (UMLS CUI [1,2])
C0229090 (UMLS CUI [1,2])
C0229090 (UMLS CUI [1,2])
C0871511 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C4295513 (UMLS CUI-2)
(Comment:en)
(Comment:en)
C0439568 (UMLS CUI-2)
C0015392 (UMLS CUI [1,2])
C0871511 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C4295513 (UMLS CUI-2)
(Comment:en)
(Comment:en)